Legacy Healthcare expands in China

TPP Healthcare successfully partners Legacy Healthcare, a Swiss-based R&D firm, with Maxhealth, a Chinese commercial healthcare firm.

Learn More

CHIPS 2018

In China, March 15-17 2018, we will be hosting 100 Western healthcare companies specializing in innovative technologies in areas that are vital to the growing Chinese healthcare industry, along with approximately 1,000 Chinese healthcare strategic partners and investors.

Learn More

#TPPINSIGHTS

Access the latest news, insight and market moves from TPP and across the industry.

Learn More

SPECIALIZING IN GLOBAL DEAL-FLOW, TARGETED AT CHINA’S BOOMING HEALTHCARE MARKET

China is relevant, accessible and seeking innovation.

The numbers are only growing across the board for healthcare needs and innovative opportunity.

0
China’s 2020 Prescription Market (billions)
0
Lung Cancer Epidemic (thousands)
0
Life science venture capital growth in one year (x)
500
TPP’s growing network

Work with us and expect real partners, deal-flow, results and progress.

TPP Healthcare prides itself as the leading platform to facilitate partnerships between both innovator and investor.

With an experienced team of well-connected industry veterans from all over the world, and the largest network in China’s healthcare industry, TPP has become the market expert with the top-notch network to execute and support cross-border transactions involving pharmaceuticals, medical devices and diagnostics.

View our Innovator Services or Investor Services expand your business today.

Contact Us

TPP has the background, credentials and understanding to execute and support transactions involving global healthcare. Our team of analysts can quickly evaluate the potential for your company or product. Contact us today to discuss immediate opportunities – or simply sign up for our quarterly reports, client break-throughs and more.






    THE PHARMA PARTNERS HEALTHCARE